Disclosure: some links in this post are affiliate links. If you buy through them, WakeHerUp may earn a commission at no extra cost to you. It never changes what we recommend. Everything here is education, not medical advice. Talk to a provider about your own body.
Frequent UTIs.
Peeing your pants.
Reaching for lube every single time.
Sex that hurts.
You decided this was just aging.
You bought the bigger pads. You started scoping out bathrooms before you sat down anywhere. You said “I’m tired” instead of “it hurts.” You stopped initiating, and then you stopped mentioning it, and then you made peace with it.
It is not aging. It is a tissue problem with a name, a mechanism, and a treatment that has been sitting on pharmacy shelves for decades.
Vaginal estrogen is the answer.
And by the time you finish this page you are going to be furious that nobody said the words out loud.
The numbers nobody put in front of you
What you have is called genitourinary syndrome of menopause, or GSM. It affects somewhere between 27% and 84% of postmenopausal women, depending on how the question gets asked (2020 GSM position statement, The Menopause Society).
In a survey of 1,858 postmenopausal women, half had never used any therapy for it. Most had never brought it up with a provider at all.
Here is why that is not your fault. A 2023 survey of US OB/GYN residency programs found that only 31.3% had a dedicated menopause curriculum. Meaning 68.7% of the programs training the doctors you go to for exactly this had no formal teaching on it (Allen et al., Menopause, 2023).
You were not too embarrassed to ask. You were sent to people who were never taught the answer.
One more thing you need to know before we go into the mechanism. Unlike hot flashes, which usually fade with time, GSM is progressive without treatment. It does not wear off. One review tracked symptom prevalence climbing from 4% in perimenopause to 25% at one year past your final period to 47% at three years (Cleveland Clinic Journal of Medicine).
Waiting is a decision. It is just a decision nobody told you that you were making.
What estrogen was actually doing for you
Your vulva, your vagina, your urethra, your bladder neck and your pelvic floor are all loaded with estrogen receptors. That tissue is not neighbors with your hormones. It is downstream of them.
When estrogen falls, this is the cascade:
- The vaginal lining goes from thick, glycogen-rich and stretchy to thin, fragile and easily torn.
- Less glycogen means less food for your lactobacilli, the good bacteria that keep the place acidic.
- Fewer lactobacilli means less lactic acid, so vaginal pH climbs above 5. Your defenses were built on acid.
- Collagen and elastin drop. Blood flow drops. Natural lubrication drops.
- The labia minora thin and regress. The vaginal canal can narrow.
- The lining of the urethra and the bladder trigone thins right along with everything else.
Read that last one again. Your bladder and your urethra are part of this. That is the piece that never gets explained, and it is the piece that explains your entire year.
Why you keep getting UTIs
You are not unhygienic. You are not doing anything wrong.
Your vagina used to be an acidic environment that E. coli could not comfortably live in. Now the pH has risen, the lactobacilli are gone, and the tissue at the opening of your urethra is thin. Bacteria colonize, then climb.
The landmark trial here is old, and the numbers are almost rude. Raz and Stamm ran a randomized, double-blind, placebo-controlled study of intravaginal estriol in postmenopausal women with recurrent UTIs, published in the New England Journal of Medicine in 1993. UTI incidence fell to 0.5 episodes per year on vaginal estrogen versus 5.9 episodes per year on placebo. Vaginal pH dropped from 5.5 to 3.6. After one month, lactobacilli had returned in 60% of the treated women and in none of the placebo group.
The Cochrane review of vaginal versus oral estrogen for UTI prevention is worth knowing too, because it draws the line clearly. Across nine trials and 3,345 women, oral estrogen did nothing for UTI risk (RR 1.08, 95% CI 0.88 to 1.33). Vaginal estrogen worked, with risk ratios of 0.25 and 0.64 in the two placebo-controlled studies (Cochrane).
In 2025 the American Urological Association, SUFU and AUGS put it in a guideline as a moderate recommendation on Grade B evidence: in patients with GSM and recurrent UTIs, clinicians should recommend local low-dose vaginal estrogen to reduce the risk of future infections (AUA/SUFU/AUGS GSM Guideline, 2025).
You have been handed antibiotics four times. Nobody treated the reason.
Why you are leaking, and why oral hormones can make it worse
Same tissue, different symptom. A thin urethra does not seal as well. A thin bladder lining is twitchier. So you get urgency, frequency, getting up at night, burning with no infection, and leaking when you laugh, sneeze or pick up a grandchild.
The Cochrane review on estrogen and urinary incontinence covered 34 trials and roughly 19,676 women, and the split in it is the single most useful fact in this whole post:
- Local vaginal estrogen may improve incontinence (RR 0.74, 95% CI 0.64 to 0.86), with fewer trips to the bathroom and less urgency.
- Systemic estrogen made incontinence worse than placebo (RR 1.32, 95% CI 1.17 to 1.48), and women who did not have incontinence were more likely to develop it (Cochrane).
Route matters more than dose. A pill or a patch is not a substitute for treating the tissue directly, and for your bladder it may not be neutral. This is exactly why women on full HRT still need vaginal estrogen if they have these symptoms. They are two different jobs.
Lube treats the symptom. Estrogen treats the cause.
Lubricant is friction relief. Use it, it is genuinely useful, and it works in the moment. But it does nothing to the tissue. There is no histologic change from lube. You are oiling a hinge that has rusted through.
Vaginal moisturizers, used regularly, do more than lube does, and hyaluronic acid inserts help some women a lot.
Prescription vaginal estrogen is the only one of the three that reverses the actual atrophy. It thickens the epithelium back up, brings the pH back down, and repopulates the lactobacilli. That is why it is the one that fixes the UTIs, and lube never will.
If you are reaching for lube every single time, that is not a preference. That is a symptom with a treatment.
What vaginal estrogen is, and how you actually use it
These are all low-dose, local, FDA-approved prescription products. They are not the same thing as HRT.
| Form | Examples | How it is used |
|---|---|---|
| Cream | Estradiol vaginal cream 0.01% (generic Estrace), conjugated estrogens cream (Premarin) | Often 0.5 g to 1 g nightly for about 2 weeks, then 1 to 3 times weekly. Flexible dosing, comes with an applicator. |
| Tablet or insert | Estradiol vaginal inserts 10 mcg (Vagifem, Yuvafem), 4 mcg or 10 mcg softgel (Imvexxy) | One insert daily for 2 weeks, then twice weekly with 3 to 4 days between doses. Least messy option. |
| Ring | Estradiol vaginal ring 2 mg (Estring), releasing about 7.5 mcg a day | You put it in and leave it for 90 days, then replace. Nothing to remember. |
How long until it works. Most women notice something within a few weeks. Give it 12 weeks for maximum benefit. Do not judge it at day 10.
How long you stay on it. As long as you want the benefit. Symptoms come back when you stop, because the underlying estrogen loss did not go anywhere. This is maintenance, not a course of treatment.
There are also prescription options that are not estrogen at all: vaginal DHEA (prasterone), which your vaginal tissue converts locally, and oral ospemifene, a daily 60 mg pill. Worth knowing if estrogen is off the table for you.
Local vaginal estrogen is not HRT. This is the part that changes the safety conversation.
Systemic hormone therapy is designed to raise estrogen levels through your whole body, which is how it treats hot flashes, night sweats, sleep and bone loss.
Low-dose vaginal estrogen is designed to stay put.
The measured numbers: with the low-dose ring, serum estradiol runs about 5 to 10 pg/mL. With the 10 mcg tablet, about 3 to 11 pg/mL. Both sit inside the normal untreated postmenopausal range, which is under 20 pg/mL.
Two consequences that matter:
- You do not need progesterone alongside low-dose vaginal estrogen if you are otherwise low risk. The Menopause Society position statement says a progestogen is not recommended with it. The AUA guideline says local low-dose vaginal estrogen does not increase the risk of endometrial hyperplasia with atypia or endometrial cancer, and that endometrial surveillance should not be done based on its use alone.
- That is completely different from systemic estrogen. If you have a uterus and you take systemic estrogen, you need progesterone with it to protect your endometrium. That rule is not optional and it does not change. Vaginal estrogen is the exception because it barely leaves the neighborhood.
And if you have any unexplained or abnormal vaginal bleeding, get it evaluated before you start anything. Bleeding needs a diagnosis first, always.
Is vaginal estrogen safe? Let’s do this head on.
You have probably picked up a box, read the insert, seen the wall of warnings about stroke, blood clots, dementia and cancer, and put it back in the drawer. Millions of women have. So has this been worth being scared of?
Where the warning came from. After the Women’s Health Initiative results in 2002, the FDA applied a boxed warning to estrogen products as a class starting in 2003. Vaginal estrogen got the same warning as a systemic pill, despite being a fundamentally different exposure. Dr. Rachel Rubin has compared it to putting IV steroid warnings on a tube of hydrocortisone cream (Let’s Talk Menopause).
What changed. On November 10, 2025, the FDA announced it is removing the boxed warnings from estrogen-containing hormone therapy products, with updated labeling expected within about six months. The boxed warning about endometrial cancer stays on systemic estrogen-only products (Harvard Health).
What the societies say. The Menopause Society backed the removal for low-dose vaginal estrogen the same day, calling it a safe and effective therapy and saying the warning “may have been a deterrent” to using it (The Menopause Society). The 2025 AUA/SUFU/AUGS guideline tells clinicians to inform patients of the absence of evidence linking local low-dose vaginal estrogen to the development of breast cancer.
So if you filled a prescription years ago, read the insert, and quietly stopped: you were reacting reasonably to a label that the FDA has now decided was wrong for this product.
If you have had breast cancer
This one gets a real answer, not a slogan, and the real answer is that it is a conversation and not a rule.
ACOG’s guidance is that non-hormonal options should be first line for urogenital symptoms in women with a history of estrogen-dependent breast cancer. If those are not enough, low-dose vaginal estrogen may be used after a risk and benefit discussion, including in women taking tamoxifen. For women on an aromatase inhibitor, ACOG calls for shared decision-making and says clear communication with your medical oncologist supports that process (ACOG Clinical Consensus, 2021).
The 2025 AUA guideline says the same thing in different words: for patients with GSM and a personal history of breast cancer, clinicians may recommend local low-dose vaginal estrogen in the context of multidisciplinary shared decision-making.
Not a blanket yes. Not a blanket no. Bring it to your oncologist and ask directly, and know that “absolutely not, ever” is not the current position of either organization.
Prescription, over the counter, or telehealth. Know which is which.
This gets blurred constantly in ads, so here it is clean.
- Over the counter: lubricants, vaginal moisturizers, hyaluronic acid suppositories, vitamin E. Helpful. Not estrogen. They do not reverse atrophy and they will not fix recurrent UTIs.
- Prescription: every actual vaginal estrogen product, cream, insert and ring. All of them require a prescription in the US. If something is sold on a shelf as a “natural estrogen cream,” it is not FDA-approved vaginal estrogen, and you have no idea what dose you are getting.
- Telehealth: still a prescription. A licensed clinician reviews your history and writes it. What telehealth removes is the three-month wait for a gynecology appointment, not the clinician.
Where 60,000 women send each other for this
None of the recommendations on this site are my opinion. They come out of a global community of more than 60,000 women who have spent over four years comparing notes on what worked, what did nothing, what was too pricey, what was actually reasonable, and which providers listen.
For vaginal estrogen, the name that keeps coming back is Interlude.
Start with who is behind it, because that is the test that matters. Interlude was co-founded in 2022 by May Allen, who runs it as CEO. She started it after watching what her own mother went through trying to get care, and after finding out how few OB/GYN programs teach menopause at all. Her line about it is that an MD or GYN who understands the importance and safety of vaginal estrogen cream can dramatically change a woman’s life. That is a woman who built the thing she could not find for someone she loved, which is the only kind of founder we point you at.
Here is honestly how it works, so nothing surprises you:
- You complete checkout and then a health profile online. There is a one-time visit fee.
- A board-certified physician licensed in your state reviews it, usually within hours, and writes the prescription. There is no video appointment.
- What ships is real FDA-approved estradiol vaginal cream 0.01%, the generic of Estrace, from a US-regulated pharmacy, with an applicator. Generic estradiol cream starts around $39, and there are also DHEA vaginal cream and a non-hormonal hyaluronic option.
- A year of refills and unlimited messaging with the clinical team are included.
- It is cash pay. Interlude does not take insurance.
Use code WAKEHERUP for $25 off.
Two honest caveats. If you have a history of breast cancer, or any unexplained vaginal bleeding, do not route this through an online questionnaire. That belongs in a room with a provider who has your full chart. And if you want someone managing your whole hormone picture and not just this one thing, you want a provider, not a product.
Which is what the WakeHerUp provider directory is for, and it is free. Every listing in it is there because a woman in this community pointed us to it. Four years of 60,000 women reporting back on who actually listened, who took their symptoms seriously, who ran the right labs, and who did not rush them out in nine minutes. No review site can do that kind of due diligence.
What to say to your provider
Women get dismissed asking for this, so do not go in soft. Read these out loud if you need to.
- “I think I have genitourinary syndrome of menopause. I want to try low-dose vaginal estrogen.”
- “I have had [number] UTIs in the last twelve months. I know local vaginal estrogen is recommended to reduce recurrence. Can we start it instead of another round of antibiotics?”
- “Sex is painful and lubricant is not fixing it. I understand lubricant treats friction and estrogen treats the tissue.”
- “I know low-dose vaginal estrogen is not systemic HRT and that serum levels stay in the postmenopausal range.”
- “I know I do not need progesterone alongside low-dose vaginal estrogen, and that endometrial surveillance is not indicated just because I am using it.”
- “I know the FDA is removing the boxed warning from these products. Can we talk about the actual evidence rather than the old label?”
- If you have had breast cancer: “I would like to discuss low-dose vaginal estrogen with you and my oncologist. ACOG says it may be used after a risk and benefit discussion. Can you two talk?”
- If you get brushed off: “I would like that documented in my chart, and I would like a referral to someone who treats GSM.”
You are allowed to ask twice. You are allowed to change providers.
The part I need you to hear
You have been managing a treatable condition with willpower and paper products.
You rearranged your sex life around it. You rearranged your car trips around it. You let a doctor hand you a fifth course of antibiotics and never once explain why your body kept doing this. You started believing that the body you have now is the body you get from here.
It is not. Local vaginal estrogen is one of the best-evidenced treatments in all of menopause care. Thirty years of trials. A guideline recommendation for your UTIs. A society telling the FDA the warning that scared you off was a deterrent to a safe therapy.
The fix existed the entire time you were making peace with it. That should make you angry, and then it should make you pick up the phone.
Keep going: our full breakdown of the best magnesium for menopause, why progesterone is the one that gives you your sleep back, and what DHEA and testosterone do for desire. Everything else lives in our education library.
You are not crazy. It is your hormones.
